Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2

Emma Åberg1, O Andreas Karlsson1, Eva Andersson1

  • 1Department of Medical Biochemistry and Microbiology , Uppsala University , BMC Box 582, SE-75123 Uppsala , Sweden.

Insights

The MDM2-p53 interaction kinetics were studied using stopped flow fluorescence. Researchers found similar association rates but varying dissociation rates for p53, p63, and p73 TADs, with minimal salt dependence.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein-protein interactions

Background:

  • The interaction between MDM2 and the p53 transactivation domain (TAD) is crucial for cell-cycle regulation and cancer.
  • While computationally studied, experimental kinetic data for this interaction, especially involving p53 paralogs, is limited.

Purpose of the Study:

  • To experimentally investigate the binding kinetics and mechanism of MDM2 with TADs from p53, p63, and p73.
  • To determine the salt dependence of these interactions and understand the role of electrostatics.

Main Methods:

  • Stopped-flow fluorescence spectroscopy was employed to monitor binding reactions.
  • Kinetic parameters (association and dissociation rate constants) were measured at 10 °C.
  • The influence of ionic strength on binding was analyzed.

Main Results:

  • Kinetics were consistent with a two-state mechanism within the stopped-flow time frame (<5 ms at 10 °C).
  • Association rate constants were similar across all three TADs.
  • Differences in dissociation rates explained varying affinities, with a surprisingly small ionic-strength dependence observed for all interactions.

Conclusions:

  • The findings suggest that initial interactions of intrinsically disordered proteins (IDPs) with MDM2 may involve extensive contacts and 'conformational funneling'.
  • Electrostatic interactions play a less dominant role than previously thought for these IDP binding events.
  • Hydrophobic and charge-charge interactions contribute to early binding stages.

Related Concept Videos

Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

2.9K
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.1K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.8K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.8K